Search Results - "STUTE, N"

In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors by KRÖGER, N, ZABELINA, T, FIEGEL, H, ERTTMANN, R, LÖLIGER, C, ZANDER, A. R, KRÜGER, W, RENGES, H, STUTE, N, RISCHEWSKI, J, SONNENBERG, S, AYUK, F, TÖGEL, F, SCHADE, U

“…One-hundred and two patients with good risk myeloid leukemia (CML first chronic phase or AML first CR) were transplanted from HLA-related donors after…”
Get full text

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome by KRÖGER, N, SCHETELIG, J, ZABELINA, T, KRÜGER, W, RENGES, H, STUTE, N, SCHRUM, J, KABISCH, H, SIEGERT, W, ZANDER, A. R

“…We investigated the feasibility and efficacy of a fludarabine-based dose-reduced conditioning regimen followed by stem cell transplantation from related (n =…”
Get full text

P 42 Pilot clinical and EEG-biomarker results of transcranial pulse stimulation in Alzheimer's disease by Wojtecki, L., Cont, C., Trenado, C., Rusch, K., Galli, A., Stute, N., Schnitzler, A.

“…Introduction: Transcranial Pulse Stimulation (TPS) is a new non-invasive neuromodulation therapy that uses shockwaves for the treatment of Alzheimeŕs Disease…”
Get full text

Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients by KROGER, N, ZABELINA, T, KRÜGER, W, RENGES, H, STUTE, N, KABISCH, H, JABURG, N, LÖLIGER, C, KRÜLL, A, ZANDER, A. R

“…We compared fractionated total body irradiation (12 Gy)/cyclophosphamide (120 mg/kg) with busulfan (16 mg/kg)/cyclophosphamide (120 mg/kg) as preparative…”
Get full text

P 50 The safety and feasibility of deep transcranial magnetic stimulation in patients with Parkinson syndromes and medical refractory symptoms: a retrospective analysis by Cont, C., Wojtecki, L., Letho, A., Stute, N., Galli, A., Schulte, C., Cont, Celine, Lehto, Annaliis, Stute, Nathalie, Galli, Anastasia, Schulte, Christina, Wojtecki, Lars

“…Introduction: Deep transcranial magnetic stimulation (dTMS) is a relatively novel, non-invasive therapeutic tool whereby magnetic fields are utilized to assert…”
Get full text

Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia by KRÖGER, N, ZABELINA, T, COLBERG, H, SONNEN, R, KUSE, R, BRAUMANN, D, METZNER, B, DEL VALLE, F, ERTTMANN, R, KABISCH, H, ZANDER, A. R, SONNENBERG, S, KRÜGER, W, RENGES, H, STUTE, N, FINKENSTEIN, F, MAYER, U, HOLSTEIN, K, FIEDLER, W

“…To evaluate the efficacy and toxicity of two different etoposide (VP-16) dosages (30 or 45 mg/kg) in combination with busulfan/cyclophosphamide as conditioning…”
Get full text

Pharmacokinetics of Subcutaneous Recombinant Human Granulocyte Colony-Stimulating Factor in Children by Stute, N., Santana, V.M., Rodman, J.H., Schell, M.J., Ihle, J.N., Evans, W.E.

“…WTH THE USE OF intensive chemotherapy for disseminated neuroblastoma and other childhood cancers, myelosuppression has become a dose-limiting…”
Get full text

Allogeneic bone marrow transplantation for refractory mantle cell lymphoma by KRÖGER, N, HOFFKNECHT, M, KRÜGER, W, ZELLER, W, RENGES, H, STUTE, N, ZSCHABER, R, ZANDER, A. R

“…We report about a 28-year-old woman with relapsed mantle cell lymphoma (MCL, centrocytic lymphoma according to the Kiel classification) refractory to salvage…”
Get full text

Drug resistance testing of acute myeloid leukemia in adults using the MTT assay by Stute, N, Köhler, T, Lehmann, L, Wetzstein, W, Ehninger, G

“…We want to evaluate the MTT in vitro assay for newly diagnosed AML in adults, in particular its prognostic significance. MTT tests were performed according to…”
Get more information

Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use by Stute, Norbert, Holtz, Katja, Bubenheim, Michael, Lange, Claudia, Blake, Felix, Zander, Axel R.

“…Mesenchymal stem cells (MSC) are promising candidates for cell-based therapies. One major obstacle for their clinical use is the biosafety of fetal calf serum…”
Get full text

The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens by STUTE, N, TRENDELENBURG, U

“…The adrenergic nerve endings of the rat vas deferens were loaded with 3H-(-)-noradrenaline; COMT was inhibited by the presence of 10 mumol/l U-0521, and all…”
Get full text

Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy by Furman, W L, Fairclough, D L, Huhn, R D, Pratt, C B, Stute, N, Petros, W P, Evans, W E, Bowman, L C, Douglass, E C, Santana, V M

“…Twenty-five children with refractory solid tumors were given recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in escalated doses…”
Get more information

Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children by Rodman, J H, Relling, M V, Stewart, C F, Synold, T W, McLeod, H, Kearns, C, Stute, N, Crom, W R, Evans, W E

“…Pharmacokinetic variability in children with cancer is substantial and confounds drawing conclusions regarding optimal therapy based only on dose-response…”
Get more information

Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis by Kröger, Nicolaus, Zabelina, Tatjana, Schieder, Heike, Panse, Jens, Ayuk, Francis, Stute, Norbert, Fehse, Natalja, Waschke, Olga, Fehse, Boris, Kvasnicka, Hans Michael, Thiele, Jürgen, Zander, Axel

“…Summary A prospective pilot study was performed to evaluate the effect of reduced‐intensity conditioning with busulphan (10 mg/kg), fludarabine (180 mg/qm) and…”
Get full text

Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? by Jaquet, Kai, Krause, Korff T, Denschel, Joachim, Faessler, Patricia, Nauerz, Mona, Geidel, Stephan, Boczor, Sigrid, Lange, Claudia, Stute, Norbert, Zander, Axel, Kuck, Karl-Heinz

“…The use of a cellular therapy offers a promising approach for the treatment of heart disease. Besides other precursor cells, bone marrow (BM)-derived stem…”
Get more information

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment‐related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T‐cell depletion with anti‐thymocyte globulin by Kröger, Nicolaus, Zabelina, Tatjana, Krüger, William, Renges, Helmut, Stute, Norbert, Schrum, Johanna, Kabisch, Hartmut, Schafhausen, Philippe, Jaburg, Nicole, Löliger, Cornelius, Schäfer, Peter, Hinke, Axel, Zander, Axel R.

“…We evaluated the cytomegalovirus (CMV) serostatus as a risk factor for survival and treatment‐related mortality (TRM) in 125 patients allografted from an…”
Get full text

Highly Efficient Retroviral Gene Transfer Based on Centrifugation-Mediated Vector Preloading of Tissue Culture Vessels by Kühlcke, Klaus, Fehse, Boris, Schilz, Andrea, Loges, Sonja, Lindemann, Carsten, Ayuk, Francis, Lehmann, Friederike, Stute, Norbert, Fauser, Axel A., Zander, Axel R., Eckert, Hans-Georg

“…Efficient retroviral gene transfer into primary cells is a prerequisite for various gene therapeutic strategies. We have developed a transduction protocol…”
Get full text

Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma by Kröger, Nicolaus, Krüger, William, Renges, Helmut, Zabelina, Tatjana, Stute, Norbert, Jung, Roman, Wittkowsky, Georg, Kuse, Rolf, Zander, Axel Rolf

“…Two patients with persistent disease after allografting for multiple myeloma received donor T‐cell lymphocyte infusion (DLI) (1·5 × 108 and 7 × 107) to induce…”
Get full text

Allogeneic hematopoetic stem cell transplantation after reduced intensity conditioning for patients with indolent or mantle cell lymphoma by Schieder, H., Kröger, N., Zabelina, T., Ayuk, F., Kratochwille, A., Fehse, B., Fehse, N., Stute, N., Renges, H., Zander, A. R.

“…Abstract only…”
Get full text

Allogeneic hematopoetic stem cell transplantation after reduced intensity conditioning for patients with indolent or mantle cell lymphoma by Schieder, H., Kröger, N., Zabelina, T., Ayuk, F., Kratochwille, A., Fehse, B., Fehse, N., Stute, N., Renges, H., Zander, A. R.

“…Abstract only…”
Get full text